Today: 21 May 2026
Browse Category

HOSE:GMD 28 February 2026 - 1 March 2026

Vietnam stocks week ahead: Ho Chi Minh VN-Index faces a settlement test after T+2 glitch

Vietnam stocks week ahead: Ho Chi Minh VN-Index faces a settlement test after T+2 glitch

Ho Chi Minh Stock Exchange will reopen Monday after a KRX system maintenance delay disrupted some T+2 settlements late last week. The VN-Index closed Friday at 1,880.33, up 0.04%, while the VN30 index fell 0.39%. Settlement issues were resolved by Friday afternoon, according to state media. Traders await Monday’s manufacturing PMI and key February economic data later in the week.
1 March 2026
······
Vietnam stocks: Ho Chi Minh Stock Exchange VN-Index ends February up as settlement snag puts March in focus

Vietnam stocks: Ho Chi Minh Stock Exchange VN-Index ends February up as settlement snag puts March in focus

VN-Index closed at 1,880.33 on Friday, up 3.1% for the week, as foreign investors turned net buyers and fertilizer and oil-and-gas stocks led gains. Trading volume reached about 858 million shares, with turnover at 33.4 trillion dong. Brokerages briefly halted some settlements after a delay at the Vietnam Securities Depository, but the system was restored by mid-afternoon. Traders await March 2 PMI and March 6 macro data.
28 February 2026
····

Stock Market Today

  • Bitmine Immersion Technologies Uplists to NYSE, Holds 5M+ ETH as Ethereum Proxy, Launches MAVAN Staking
    May 21, 2026, 12:11 AM EDT. Bitmine Immersion Technologies (NYSE:BMNR) has become a major Ethereum proxy by accumulating over 5 million ETH, representing more than 4.3% of Ethereum's total supply. The company uplisted to the NYSE and introduced MAVAN, an institutional-grade Ethereum staking platform, shifting its focus beyond mining to include staking services. BMNR stock closed at $19.39, trading below analyst targets and experiencing recent price declines despite longer-term gains. Investors should watch Ethereum price trends, staking yields, and institutional adoption of MAVAN, while noting BMNR remains loss-making and has diluted shareholders.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop